Autologous peripheral blood stem cell transplantation for chronic acquired demyelinating neuropathy

Journal of the Peripheral Nervous System

Volumn 14, Issue 2, 2009, Pages 118-124

  Mahdi Rogers, Mohamed ^a   Kazmi, Majid ^b   Ferner, Rosalie ^a   Hughes, Richard A C ^a,d   Renaud, Susanne ^c   Steck, Andreas J ^c   Fuhr, Peter ^c   Halter, Jörg ^c   Gratwohl, Alois ^c   Tyndall, Alan ^c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

^d NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Chronic inflammatory demyelinating polyradiculoneuropathy; Paraprotein associated demyelinating neuropathy; Peripheral blood stem cell transplant; POEMS syndrome

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; ANTIBODY; AZATHIOPRINE; BETA INTERFERON; CEFEPIME; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FLUDARABINE; GABAPENTIN; GANCICLOVIR; HEPATITIS A VACCINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN M; INFLUENZA VACCINE; M PROTEIN; MELPHALAN; METHOTREXATE; METRONIDAZOLE; MORPHINE; MYCOPHENOLIC ACID; PARAPROTEIN; PNEUMOCOCCUS VACCINE; PREDNISOLONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RITUXIMAB; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; ADVERSE OUTCOME; AGED; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; CLINICAL ARTICLE; COLITIS; DEMYELINATING NEUROPATHY; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEBRILE NEUTROPENIA; FEMALE; HEPATITIS A; HUMAN; HUMAN TISSUE; INFLUENZA; MALE; NERVE; NEUROPATHIC PAIN; PNEUMOCOCCAL INFECTION; PNEUMONIA; POEMS SYNDROME; PRIORITY JOURNAL; RELAPSE; REMISSION; SEPTICEMIA; TREATMENT RESPONSE;

EID: 69249121211     PISSN: 10859489     EISSN: 15298027     Source Type: Journal    
DOI: 10.1111/j.1529-8027.2009.00221.x     Document Type: Article

References (36)

1. Axelson HW, Oberg G, Askmark H (2008a). No benefit of treatment with cyclophosphamide and autologous blood stem cell transplantation in multifocal motor neuropathy. Acta Neurol Scand 117:432-434. (Pubitemid 351643672)
2. Axelson HW, Oberg G, Askmark H (2008b). Successful repeated treatment with high dose cyclophosphamide and autologous blood stem cell transplantation in CIDP. J Neurol Neurosurg Psychiatry 79:612-614. (Pubitemid 351571891)
3. Barreira AA, Marques W Jr, Rezende C, de Souza DGB, Voltarelli J (2007). Autologous stem cell transplantation of a patient with chronic inflammatory neuropathy and persistent conduction block. J Peripher Nerv Syst 12:7.
4. Bensinger WI, Clift R, Martin P, Appelbaum FR, Demirer T, Gooley T, Lilleby K, Rowley S, Sanders J, Storb R, Buckner CD (1996). Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparisonwithmarrow transplantation. Blood 88:2794-2800. (Pubitemid 26327536)
5. Brannagan TH III, Pradhan A, Heiman-Patterson T, Winkelman AC, Styler MJ, Topolsky DL, Crilley PA, Schwartzman RJ, Brodsky I, Gladstone DE (2002). High-dose cyclophosphamide without stem-cell rescue for refractory CIDP. Neurology 58:1856-1858. (Pubitemid 34663593)
6. Choudhary PP, Thompson N, Hughes RA (1995). Improvement following interferon beta in chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol 242:252-253.
7. Coles AJ, Cox A, Le Page E, Jones J, Trip SA, Deans J, Seaman S, Miller DH, Hale G, Waldmann H, Compston DA (2006). The window of therapeutic opportunity in multiple sclerosis: evidence from monoclonal antibody therapy. J Neurol 253:98-108. (Pubitemid 43157395)
8. Daikeler T, Tyndall A (2007). Autoimmunity following haematopoietic stem-cell transplantation. Best Pract Res Clin Haematol 20:349-360. (Pubitemid 46585970)
9. Dalakas MC, Rakocevic G, Salajegheh M, Dambrosia JM, Hahn AF, Raju R, McElroy B (2009). Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein antibody demyelinating neuropathy. Ann Neurol 65:285-293.
10. Dispenzieri A, Lacy MQ, Hayman SR, Kumar SK, Buadi F, Dingli D, Litzow MR, Gastineau DA, Inwards DJ, Elliott MA, Micallef IN, Ansell SM, Hogan WJ, Porrata LF, Johnston PA, Afessa B, Bryce A, Kyle RA, Gertz MA (2008). Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome. Eur J Haematol 80:397-406.
11. Fialho D, Chan YC, Allen DC, Reilly MM, Hughes RA (2006). Treatment of chronic inflammatory demyelinating polyradiculoneuropathy with methotrexate. J Neurol Neurosurg Psychiatry 77:544-547.
12. Gratwohl A, Passweg J, Bocelli-Tyndall C, Fassas A, van Laar JM, Farge D, Andolina M, Arnold R, Carreras E, Finke J, Kotter I, Kozak T, Lisukov I, Lowenberg B, Marmont A, Moore J, Saccardi R, Snowden JA, van den Hoogen F, Wulffraat NM, Zhao XW, Tyndall A; Autoimmune Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT) (2005). Autologous hematopoietic stem cell transplantation for autoimmune diseases. Bone Marrow Transplant 35:869-879. (Pubitemid 40667629)
13. Hirst C, Raasch S, Llewelyn G, Robertson N (2006). Remission of chronic inflammatory demyelinating polyneuropathy after alemtuzumab (Campath 1H). J Neurol Neurosurg Psychiatry 77:800-802. (Pubitemid 43837219)
14. Joint Task Force of the EFNS and the PNS (2005). European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy. Report of a Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Society. J Peripher Nerv Syst 10:220-228.
15. Kazmi MA, Mahdi-Rogers M, Sanvito L (2008). Chronic inflammatory demyelinating polyradiculoneuropathy: A role for haematopoietic stem cell transplantation? Autoimmunity 28:1.
16. Kleyweg RP, van der Meche FG, Schmitz PI (1991). Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barre syndrome. Muscle Nerve 14:1103-1109.
17. Kuwabara S, Dispenzieri A, Arimura K, Misawa S (2008a). Treatment for POEMS (polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes) syndrome. Cochrane Database Syst Rev 2008:CD006828. (Pubitemid 351805399)
18. Kuwabara S, Misawa S, Kanai K, Suzuki Y, Kikkawa Y, Sawai S, Hattori T, Nishimura M, Nakaseko C (2008b). Neurologic improvement after peripheral blood stem cell transplantation in POEMS syndrome. Neurology 71:1691-1695.
19. Lee YC, Came N, Schwarer A, Day B (2002). Autologous peripheral blood stem cell transplantation for peripheral neuropathy secondary to monoclonal gammopathy of unknown significance. Bone Marrow Transplant 30:53-56. (Pubitemid 34905831)
20. Leibowitz S, Gregson NA, Kennedy M, Kahn SN (1983). IgM paraproteins with immunological specificity for a Schwann cell component and peripheral nerve myelin in patients with polyneuropathy. J Neurol Sci 59:153-165.
21. Lorenzoni PJ, Scola RH, Carsten AL, Trentin AP, Teive HA, Pasquini R, Werneck LC (2007). Chronic inflammatory demyelinating polyradiculoneuropathy in chronic graft-versus- host disease following allogeneic hematopoietic stem cell transplantation: case report. Arq Neuropsiquiatr 65:700-704. (Pubitemid 47451102)
22. Lunn MP, Nobile-Orazio E (2003). Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies. Cochrane Database Syst Rev 2003:CD002827.
23. Mahdi-Rogers M, Hughes RAC, Kazmi M, Ferner R (2007). Autologous peripheral blood progenitor cell transplantation for chronic inflammatory demyelinating polyradiculoneuropathy. J Peripher Nerv Syst 12(Suppl. 1):55.
24. McKendry RJ, Huebsch L, Leclair B (1996). Progression of rheumatoid arthritis following bone marrow transplantation. A case report with a 13-year follow-up. Arthritis Rheum 39:1246-1253.
25. Nobile-Orazio E, Meucci N, Baldini L, Di TA, Scarlato G (2000). Long-term prognosis of neuropathy associated with anti-MAG IgM M-proteins and its relationship to immune therapies. Brain 123:710-717. (Pubitemid 30162720)
26. Oyama Y, Craig RM, Traynor AE, Quigley K, Statkute L, Halverson A, Brush M, Verda L, Kowalska B, Krosnjar N, Kletzel M, Whitington PF, Burt RK (2005). Autologous hematopoietic stem cell transplantation in patients with refractory Crohn's disease. Gastroenterology 128:552-563. (Pubitemid 40585356)
27. Oyama Y, Sufit R, Loh Y, Statkute L, Yaung K, Quigley K, Gonda E, Spahovic D, Bronesky D, Burt RK (2007). Nonmyeloablative autologous hematopoietic stem cell transplantation for refractory CIDP. Neurology 69:1802-1803. (Pubitemid 350059310)
28. Pritchard J, Mukherjee R, Hughes RAC (2002). The risk of relapse of Guillain-Barre syndrome or chronic inflammatory demyelinating polyradiculoneuropathy following immunisation. J Neurol Neurosurg Psychiatry 73:348-349. (Pubitemid 34953665)
29. Remenyi P, Masszi T, Borbenyi Z, Soos J, Siklos L, Englelhardt J (2007). CIDP cured by allogeneic hematopoietic stem cell transplantation. Eur J Neurol 14:e1-e2.
30. Rudnicki SA, Harik SI, Dhodapkar M, Barlogie B, Eidelberg D (1998). Nervous system dysfunction in Waldenstrom's macroglobulinemia: response to treatment. Neurology 51:1210-1213. (Pubitemid 28473436)
31. Su L, Xu J, Ji BX, Wan SG, Lu CY, Dong HQ, Yu YY, Lu DP (2006). Autologous peripheral blood stem cell transplantation for severe multiple sclerosis. Int J Hematol 84:276-281. (Pubitemid 44619252)
32. Thomann S, Halter J, Gratwohl A, Kappos L, Steck AJ, Fuhr P, Tyndall A, Renaud S (2008). Autologous stem-cell transplantation as therapeutic option of therapy resistant CIDP. Schweizer Archiv fur Neurologie und Psychiatrie 159:447.
33. Valldeoriola F, Graus F, Steck AJ, Munoz E, de la Fuente M, Gallart T, Ribalta T, Bombi JA, Tolosa E (1993). Delayed appearance of anti-myelin- associated glycoprotein antibodies in a patient with chronic demyelinating polyneuropathy. Ann Neurol 34:394-396. (Pubitemid 23259609)
34. Vermeulen M, van Oers MH (2002). Successful autologous stem cell transplantation in a patient with chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry 72:127-128. (Pubitemid 34073115)
35. Vermeulen M, van Oers MH (2007). Relapse of chronic inflammatory demyelinating polyneuropathy 5 years after autologous stem cell transplantation. J Neurol Neurosurg Psychiatry 78:1154.
36. Vigouroux S, Michallet M, Porcher R, Attal M, Ades L, Bernard M, Blaise D, Tabrizi R, Garban F, Cassuto JP, Chevalier P, Facon T, Ifrah N, Renaud M, Tilly H, Vernant JP, Kuentz M, Bourhis JH, Bordigoni P, Deconinck E, Lioure B, Socie G, Milpied N; French Society of Bone Marrow Graft Transplantation and Cellular Therapy (SFGM-TC) (2007). Long-term outcomes after reduced-intensity conditioning allogeneic stem cell transplantation for low-grade lymphoma: a survey by the French Society of Bone Marrow Graft Transplantation and Cellular Therapy (SFGM-TC). Haematologica 92: 627-634.